FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2468684301> ?p ?o ?g. }

• W2468684301 endingPage "2452" @default.
• W2468684301 startingPage "2448" @default.
• W2468684301 abstract "Background and Objective Elevated alkaline phosphatase (ALP) is considered as a marker of liver function in clinical practice. Furthermore, it has been identified that liver function can contribute to hemorrhagic transformation (HT). However, whether ALP levels play a role in HT after stroke remains an open question, especially in cardioembolic stroke patients. Methods We prospectively and consecutively enrolled ischemic stroke patients with atrial fibrillation and/or rheumatic heart disease. Baseline data including ALP levels within 48 hours after admission were collected. ALP levels were divided into tertiles. The presence of HT, hemorrhagic infarction (HI), parenchymal hematoma (PH), and symptomatic HT was evaluated according to brain magnetic resonance imaging and European-Australasian Acute Stroke Study III definitions. We used logistic regression to examine the associations between ALP levels and risk of HT, HI, PH, and symptomatic HT. Results Of the 130 patients (56 male; mean age: 63 years) included finally, 50 (38.5%) developed HT and 13 (10.0%) developed symptomatic HT. ALP levels were not associated with risk of HT, HI, and PH. However, compared with the first ALP tertile, patients in the third tertile were 8.96 times more likely to have symptomatic HT (95% confidence interval: 1.33-60.21; P = .02) after adjusting for age, gender, alanine aminotransferase levels, aspartate aminotransferase levels, antiplatelet therapy, anticoagulation therapy, and thrombolysis therapy. Conclusion Elevated ALP levels may help identify high-risk symptomatic HT in ischemic stroke patients with atrial fibrillation and/or rheumatic heart disease. However, further studies with larger cohorts are needed to identify our results. Elevated alkaline phosphatase (ALP) is considered as a marker of liver function in clinical practice. Furthermore, it has been identified that liver function can contribute to hemorrhagic transformation (HT). However, whether ALP levels play a role in HT after stroke remains an open question, especially in cardioembolic stroke patients. We prospectively and consecutively enrolled ischemic stroke patients with atrial fibrillation and/or rheumatic heart disease. Baseline data including ALP levels within 48 hours after admission were collected. ALP levels were divided into tertiles. The presence of HT, hemorrhagic infarction (HI), parenchymal hematoma (PH), and symptomatic HT was evaluated according to brain magnetic resonance imaging and European-Australasian Acute Stroke Study III definitions. We used logistic regression to examine the associations between ALP levels and risk of HT, HI, PH, and symptomatic HT. Of the 130 patients (56 male; mean age: 63 years) included finally, 50 (38.5%) developed HT and 13 (10.0%) developed symptomatic HT. ALP levels were not associated with risk of HT, HI, and PH. However, compared with the first ALP tertile, patients in the third tertile were 8.96 times more likely to have symptomatic HT (95% confidence interval: 1.33-60.21; P = .02) after adjusting for age, gender, alanine aminotransferase levels, aspartate aminotransferase levels, antiplatelet therapy, anticoagulation therapy, and thrombolysis therapy. Elevated ALP levels may help identify high-risk symptomatic HT in ischemic stroke patients with atrial fibrillation and/or rheumatic heart disease. However, further studies with larger cohorts are needed to identify our results." @default.
• W2468684301 created "2016-07-22" @default.
• W2468684301 creator A5014020226 @default.
• W2468684301 creator A5015215059 @default.
• W2468684301 creator A5016099230 @default.
• W2468684301 creator A5017250084 @default.
• W2468684301 creator A5032363583 @default.
• W2468684301 creator A5035768608 @default.
• W2468684301 creator A5061989929 @default.
• W2468684301 creator A5080621289 @default.
• W2468684301 creator A5083835532 @default.
• W2468684301 date "2016-10-01" @default.
• W2468684301 modified "2023-10-16" @default.
• W2468684301 title "Increased Serum Alkaline Phosphatase as a Predictor of Symptomatic Hemorrhagic Transformation in Ischemic Stroke Patients with Atrial Fibrillation and/or Rheumatic Heart Disease" @default.
• W2468684301 cites W1499075785 @default.
• W2468684301 cites W1899123775 @default.
• W2468684301 cites W1964835867 @default.
• W2468684301 cites W1968737649 @default.
• W2468684301 cites W1975025595 @default.
• W2468684301 cites W1991363936 @default.
• W2468684301 cites W2011745548 @default.
• W2468684301 cites W2015848855 @default.
• W2468684301 cites W2018409191 @default.
• W2468684301 cites W2026656008 @default.
• W2468684301 cites W2027970223 @default.
• W2468684301 cites W2034107844 @default.
• W2468684301 cites W2036513699 @default.
• W2468684301 cites W2038253181 @default.
• W2468684301 cites W2039733718 @default.
• W2468684301 cites W2070793750 @default.
• W2468684301 cites W2073742622 @default.
• W2468684301 cites W2080504768 @default.
• W2468684301 cites W2082514992 @default.
• W2468684301 cites W2083108673 @default.
• W2468684301 cites W2090226276 @default.
• W2468684301 cites W2111519145 @default.
• W2468684301 cites W2120309176 @default.
• W2468684301 cites W2127985968 @default.
• W2468684301 cites W2133740367 @default.
• W2468684301 cites W2136916825 @default.
• W2468684301 cites W2140958279 @default.
• W2468684301 cites W2143212953 @default.
• W2468684301 cites W2154280994 @default.
• W2468684301 cites W2170098955 @default.
• W2468684301 cites W2259193443 @default.
• W2468684301 cites W4247088564 @default.
• W2468684301 doi "https://doi.org/10.1016/j.jstrokecerebrovasdis.2016.06.017" @default.
• W2468684301 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27425768" @default.
• W2468684301 hasPublicationYear "2016" @default.
• W2468684301 type Work @default.
• W2468684301 sameAs 2468684301 @default.
• W2468684301 citedByCount "17" @default.
• W2468684301 countsByYear W24686843012017 @default.
• W2468684301 countsByYear W24686843012018 @default.
• W2468684301 countsByYear W24686843012019 @default.
• W2468684301 countsByYear W24686843012020 @default.
• W2468684301 countsByYear W24686843012021 @default.
• W2468684301 countsByYear W24686843012022 @default.
• W2468684301 crossrefType "journal-article" @default.
• W2468684301 hasAuthorship W2468684301A5014020226 @default.
• W2468684301 hasAuthorship W2468684301A5015215059 @default.
• W2468684301 hasAuthorship W2468684301A5016099230 @default.
• W2468684301 hasAuthorship W2468684301A5017250084 @default.
• W2468684301 hasAuthorship W2468684301A5032363583 @default.
• W2468684301 hasAuthorship W2468684301A5035768608 @default.
• W2468684301 hasAuthorship W2468684301A5061989929 @default.
• W2468684301 hasAuthorship W2468684301A5080621289 @default.
• W2468684301 hasAuthorship W2468684301A5083835532 @default.
• W2468684301 hasConcept C126322002 @default.
• W2468684301 hasConcept C127413603 @default.
• W2468684301 hasConcept C160160445 @default.
• W2468684301 hasConcept C164705383 @default.
• W2468684301 hasConcept C181199279 @default.
• W2468684301 hasConcept C185592680 @default.
• W2468684301 hasConcept C2779161974 @default.
• W2468684301 hasConcept C2779581417 @default.
• W2468684301 hasConcept C2780645631 @default.
• W2468684301 hasConcept C44249647 @default.
• W2468684301 hasConcept C500558357 @default.
• W2468684301 hasConcept C55493867 @default.
• W2468684301 hasConcept C71924100 @default.
• W2468684301 hasConcept C78519656 @default.
• W2468684301 hasConcept C90924648 @default.
• W2468684301 hasConceptScore W2468684301C126322002 @default.
• W2468684301 hasConceptScore W2468684301C127413603 @default.
• W2468684301 hasConceptScore W2468684301C160160445 @default.
• W2468684301 hasConceptScore W2468684301C164705383 @default.
• W2468684301 hasConceptScore W2468684301C181199279 @default.
• W2468684301 hasConceptScore W2468684301C185592680 @default.
• W2468684301 hasConceptScore W2468684301C2779161974 @default.
• W2468684301 hasConceptScore W2468684301C2779581417 @default.
• W2468684301 hasConceptScore W2468684301C2780645631 @default.
• W2468684301 hasConceptScore W2468684301C44249647 @default.
• W2468684301 hasConceptScore W2468684301C500558357 @default.
• W2468684301 hasConceptScore W2468684301C55493867 @default.
• W2468684301 hasConceptScore W2468684301C71924100 @default.
• W2468684301 hasConceptScore W2468684301C78519656 @default.
• W2468684301 hasConceptScore W2468684301C90924648 @default.

• next